rediff.com
News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

Rediff.com  » Sports » EPL's bad boys: Toure fined for doping; Wigan's Alcaraz gets ban
This article was first published 13 years ago

EPL's bad boys: Toure fined for doping; Wigan's Alcaraz gets ban

Last updated on: November 9, 2011 11:05 IST

Image: Kolo Toure
Photographs: Getty Images

Defender Kolo Toure has accepted a six-week fine from Manchester City after the Ivorian international failed a drugs test earlier this year, the Premier League leaders said.

Toure, who resumed playing in September after serving a six-month ban, failed a test after taking a diet pill that was not intended to enhance his performance.

"Following the conclusion of an internal disciplinary process, Manchester City Football Club can confirm that Kolo Toure has received a fine of six weeks' wages which relates to doping offences committed by him earlier this year," City said in a statement.

"Kolo accepts the decision and he and the club now wish to draw a line under this matter and focus on the season ahead."

Since returning from his ban Toure has featured just twice for City, with both appearances coming in the League Cup.

Wigan's Alcaraz gets 3-match ban for spitting

Image: Antolin Alcaraz
Photographs: Getty Images

Wigan Athletic captain Antolin Alcaraz was banned for three matches on Tuesday after admitting a charge of spitting at an opponent during a Premier League match, the English Football Association said in a statement on its website (www.thefa.com).

The 19-year-old Paraguayan defender was caught by television cameras spitting at Wolverhampton Wanderers player Richard Stearman in an incident missed by the match officials on Sunday.

Wigan are bottom of the table following eight successive defeats and Alcaraz will miss the games against Blackburn Rovers, Sunderland and Arsenal.

Source: REUTERS
© Copyright 2024 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.